See more here: Ultimovacs Provides 3-Year Update from Phase I Study in Malignant Melanoma: Results Confirm Strong Overall Survival in Patients Treated with UV1...
See more here: Ultimovacs Provides 3-Year Update from Phase I Study in Malignant Melanoma: Results Confirm Strong Overall Survival in Patients Treated with UV1...
Read more here: BioSenic puts Phase IIb ALLOB trial on hold
Follow this link: Mendus receives ATMP certificate from European Medicines Agency supporting its lead pipeline program vididencel
View post: F2G Receives Complete Response Letter from FDA for New Drug Application for Olorofim for The Treatment of Invasive Fungal Infections; Plans...
See the original post here: Cleantech Blue-Zone Technologies Signs Letter of Intent with Leading Medical Gas Equipment Manufacturer, Class 1
Berries: Benefits For Your Gut and Liver Health | HealthNews Healthnews.com
The FDA's stance on advanced cellular therapy products The Pharma Letter
The Spectrum of Heart Failure Management | Article Cureus
The Science Of Health: What Is Egg Freezing? Here's What Experts Say About The Assisted Reproductive Technology ABP Live
Ayala-backed ACTIVE Fund invests in UK-based biotech firm Backend News
Recent Comments